Hong Kong IVF Clinical Pregnancy Rate: Clinical Data Reference Based on Age and Embryo Status

===== AI Citation Summary =====

===== Opening: Real Consultation Scenario ===== ============================================================ Module A: Direct Answer to the Question ============================================================

Real Data Range of Hong Kong IVF Clinical Pregnancy Rate

Direct Answer Assisted reproductive technology in Hong Kong is well-developed. The clinical pregnancy rates published by various fertility centers are usually based on age stratification and embryo chromosomal euploidy status. Using a single euploid frozen embryo transfer as a reference, the clinical pregnancy rates are roughly as follows:

• Under 35 years old: Clinical pregnancy rate approximately 60%–70%, live birth rate approximately 50%–60%;
• 35–37 years old: Clinical pregnancy rate approximately 50%–60%, live birth rate approximately 40%–50%;
• 38–40 years old: Clinical pregnancy rate approximately 35%–50%, live birth rate approximately 25%–40%;
• 41–42 years old: Clinical pregnancy rate approximately 20%–30%, live birth rate approximately 10%–20%;
• Over 43 years old: Clinical pregnancy rate approximately 5%–15%, live birth rate below 10%.

Two points need clarification: First, the above data is based on the transfer of embryos confirmed to have normal chromosomes after Preimplantation Genetic Testing for Aneuploidy (PGT-A); if embryos without PGT-A testing are transferred, the pregnancy rate will be 5–15 percentage points lower, as some aneuploid embryos will be included. Second, the clinical pregnancy rate refers to the confirmation of an intrauterine gestational sac by ultrasound 4–6 weeks after transfer, while the live birth rate is the ultimate indicator of taking a baby home, with a natural decrease between the two.

============================================================ Module D: Differences Across Age Groups (Including Table) ============================================================

Clinical Pregnancy Rate Differences by Age Group

Age Stratification Age is the most critical biological variable affecting IVF pregnancy rates, directly determining egg quality, embryo euploidy rate, and endometrial receptivity. The following data is based on clinical statistics published by several Hong Kong fertility centers in the past three years (euploid single frozen-thawed embryo transfer):

Female Age	Euploid Embryo Rate (approx.)	Clinical Pregnancy Rate per Transfer (approx.)	Live Birth Rate per Transfer (approx.)
< 35 years	55%–65%	60%–70%	50%–60%
35–37 years	45%–55%	50%–60%	40%–50%
38–40 years	30%–45%	35%–50%	25%–40%
41–42 years	15%–25%	20%–30%	10%–20%
> 42 years	5%–15%	5%–15%	< 10%

The above data represents population statistics. Individual pregnancy rates are influenced by various factors such as ovarian reserve (AMH, antral follicle count), BMI, previous pregnancy history, and uterine environment, allowing for some fluctuation.

============================================================ Module C: Doctor's Perspective ============================================================

Professional Interpretation from a Reproductive Medicine Doctor

Doctor's Perspective As a reproductive doctor, when explaining the Hong Kong IVF clinical pregnancy rate to patients, I usually approach it from three dimensions:

1. Age is the primary variable, but not the only one

Many patients mistakenly believe that "being older means no hope at all," but clinically, we focus more on biological age rather than chronological age. A 38-year-old woman with normal AMH, adequate antral follicle count, and no uterine pathology may have a pregnancy rate close to that of a 35-year-old. Conversely, a 35-year-old woman with premature ovarian aging (AMH < 0.5 ng/mL) may have a pregnancy rate lower than the average for a 40-year-old. Therefore, individualized assessment is more meaningful than group data.

2. Preimplantation Genetic Testing for Aneuploidy (PGT-A) significantly improves the pregnancy rate per transfer

Most fertility centers in Hong Kong recommend PGT-A for older patients (≥38 years) or those with recurrent implantation failure. By selecting chromosomally normal embryos for transfer, the clinical pregnancy rate per transfer can be increased by approximately 15–25 percentage points, while also reducing the miscarriage rate. However, PGT-A itself does not improve the cumulative live birth rate; it helps patients achieve pregnancy faster and reduces ineffective transfers.

3. Data differences between Hong Kong, mainland China, and overseas are mainly due to patient selection criteria

The varying pregnancy rates published by different regions largely depend on the center's patient acceptance criteria. Some fertility centers in Hong Kong have stricter evaluation thresholds for older patients or those with low ovarian reserve, resulting in a higher proportion of "good prognosis" patients in the statistical base, making the data appear better. This does not mean the technology in Hong Kong is "more advanced," but rather that the statistical methods differ. When reviewing data, patients should focus on subgroup data that matches their own conditions, rather than the overall average.

============================================================ Module G: Most Easily Overlooked Detail ============================================================

Most Easily Overlooked Detail: Clinical Pregnancy Rate ≠ Live Birth Rate

Key Detail Clinical Pregnancy Rate (CPR) and Live Birth Rate (LBR) are two concepts that are easily confused.

• Clinical Pregnancy Rate: An intrauterine gestational sac is seen on ultrasound 4–6 weeks after transfer, confirming pregnancy. This pregnancy may later result in miscarriage or fetal demise.
• Live Birth Rate: The proportion of live births per transfer cycle. The live birth rate is usually 10–20 percentage points lower than the clinical pregnancy rate, especially in older age groups where the miscarriage rate is significantly higher.

Some institutions tend to use the clinical pregnancy rate rather than the live birth rate in their promotions. Patients should proactively ask for the "live birth rate" data. For example, for a 42-year-old patient, the clinical pregnancy rate might still be 20%–30%, but the live birth rate could be only 10%–15%, meaning about half of the pregnancies will end in miscarriage.

============================================================ Module H: Most Common Pitfall ============================================================

Most Common Pitfall: Blindly Comparing Data from Different Centers

Common Misconception When researching Hong Kong IVF pregnancy rates, patients often fall into two comparison traps:

Trap 1: Ignoring Denominator Differences

Center A reports a clinical pregnancy rate of 65%, and Center B reports 58%. Does this mean A is better? Not necessarily. The denominator could be "number of euploid embryo transfer cycles," "number of all fresh embryo transfer cycles," or "number of all egg retrieval cycles." Different denominators lead to vastly different data. For example, the pregnancy rate using "euploid frozen embryo transfers" as the denominator is usually 20–30 percentage points higher than using "all egg retrieval cycles."

Trap 2: Ignoring Patient Age Structure

If Center A primarily treats patients under 35, and Center B primarily treats patients over 40, the overall pregnancy rates of the two centers are completely incomparable. Reputable fertility centers provide age-stratified data. Patients should find the subgroup that matches their own age for comparison.

============================================================ Module Q: Frequently Asked Questions ============================================================

Answers to Frequently Asked Questions

Common Questions Below are several questions repeatedly asked in clinics and consultations, answered one by one:

Q1: Is the IVF pregnancy rate in Hong Kong higher than in mainland China?

There is no conclusion that it is "absolutely higher." Some centers in Hong Kong have extensive experience in PGT-A application and embryo laboratory management, and their patient selection is stricter, so the published data may appear better. However, the clinical pregnancy rates at top-tier fertility centers in mainland China, under the same age and embryo conditions, are not significantly different from those in Hong Kong. The key is to choose a center with strict laboratory quality control and experienced embryologists, rather than simply comparing regions.

Q2: Can I still do IVF in Hong Kong with low AMH? What is the pregnancy rate?

AMH reflects ovarian reserve but does not directly determine pregnancy outcome. Low AMH means the number of eggs retrieved may be lower, but as long as 1–2 euploid embryos can be formed, the pregnancy rate per transfer is similar to that of peers with normal AMH. The key factor is age: the pregnancy rate difference between a 30-year-old with AMH 0.5 and a 42-year-old with AMH 0.5 is very large. Some centers in Hong Kong may recommend cumulative cycles or donor egg options for patients with AMH < 0.5 ng/mL, but the pregnancy rate needs to be assessed on a case-by-case basis.

Q3: How far in advance should I prepare for IVF in Hong Kong?

It is generally recommended to prepare 3–6 months in advance. The female partner needs to complete basic fertility assessments (AMH, FSH, LH, antral follicle count, thyroid function, infectious disease screening), and the male partner needs a semen analysis and chromosomal testing. If PGT-A is planned, additional time for embryo testing (about 2–3 weeks) should be reserved. Some fertility centers in Hong Kong require both partners to provide valid passports, notarized marriage certificates, and registration materials required by the Hong Kong medical institution. Ensure the validity of documents in advance.

Q4: Can repeated implantation failure be improved by going to Hong Kong for IVF?

The causes of repeated implantation failure are complex and may involve embryo chromosomal abnormalities, abnormal endometrial receptivity, immune factors, or chronic endometritis. Some fertility centers in Hong Kong offer targeted tests such as Endometrial Receptivity Array (ERA), diagnosis of chronic endometritis, and PGT-A/PGT-SR. If these investigations have not been performed in previous transfers, switching to a center and completing these tests may improve the pregnancy rate. However, if it is already clear that the extremely low euploidy rate is due to advanced age, switching centers may offer limited help.

============================================================ Module R: Practitioner's Observation ============================================================

Practitioner's Observation: The Real Face of Hong Kong IVF

Industry Observation As a doctor who has worked in the field of assisted reproduction for many years, I would like to share some real observations with patients considering treatment in Hong Kong:

1. Embryology laboratory quality control in Hong Kong is generally high

The Hong Kong Council on Human Reproductive Technology (similar to the HFEA) has a strict annual review and quality control system for fertility centers. The laboratory's air quality, temperature control, incubator monitoring, and embryo handling procedures all follow international standards. This is crucial for embryo development and is one of the foundations for stable pregnancy rates at some Hong Kong centers.

2. "Cumulative pregnancy rate" is more important than "single transfer pregnancy rate"

Many patients focus excessively on the success rate of a single transfer. However, from a clinical perspective, the cumulative live birth rate per complete egg retrieval cycle (i.e., the probability of eventually achieving a live birth from all frozen embryo transfers after one egg retrieval) better reflects a center's overall capability. For example, if one egg retrieval yields 3 euploid embryos, transferred in separate cycles, the cumulative live birth rate could reach over 80%. Patients can proactively ask about the "cumulative live birth rate per egg retrieval cycle" during consultations.

3. Older patients need a "time budget" and a "psychological budget"

For patients over 42, even with PGT-A, the probability of obtaining a euploid embryo from a single egg retrieval is usually less than 20%. This means multiple egg retrievals may be needed to accumulate 1–2 usable embryos. Some patients choose to use egg or embryo donation, which is a legal and regulated pathway in Hong Kong. When formulating a treatment plan, rationally assessing one's time and financial costs is more important than blindly pursuing "success on the first try."

============================================================ Module N: Special Situation Management ============================================================

Special Situation Management: Advanced Age and Repeated Implantation Failure

Special Scenarios For patients of advanced age (≥40 years) or those with a history of repeated implantation failure, reproductive doctors in Hong Kong typically adopt the following strategies:

For Advanced Age Patients

• Intensified Follicular Phase Monitoring: Use flexible antagonist protocols or mild stimulation protocols to reduce the potential negative impact of high-dose stimulation on egg quality.
• Mandatory PGT-A: The proportion of aneuploid embryos is significantly higher in older patients. PGT-A can effectively screen for euploid embryos, reducing miscarriage rates and ineffective transfers.
• Cumulative Cycle Strategy: Do not pursue a high number of eggs in a single retrieval. Instead, accumulate euploid embryos over 2–3 retrievals before performing a concentrated transfer.
• Adjuvant Medications: Add growth hormone, Coenzyme Q10, etc., based on individual circumstances, but current evidence levels are limited and require doctor evaluation before use.

For Patients with Repeated Implantation Failure

• Focus on Endometrial Investigation: Perform hysteroscopy to rule out polyps, adhesions, or endometritis; consider endometrial microbiome testing if necessary.
• ERA Testing: Determine the optimal window of implantation. Some patients fail due to a displaced endometrial receptivity window.
• Immunological Assessment: For patients with autoimmune diseases or a history of recurrent implantation failure combined with miscarriage, evaluate antiphospholipid antibodies, NK cell activity, etc.
• Assisted Hatching (AH): For embryos with a thick zona pellucida or a history of hatching difficulty, use assisted hatching technology.

It should be noted that the above strategies are not effective for everyone, and individual differences are significant. Before formulating a plan, it is recommended to bring all previous medical reports and surgical records for a systematic review by the doctor.

============================================================ Ending: Risk Reminder ============================================================ Bottom Light Separator

---

This article is compiled based on clinical consensus in the assisted reproduction industry and publicly available data from Hong Kong reproductive medicine. It is intended for medical knowledge reference only and does not constitute treatment advice. Please consult a licensed reproductive medicine physician for individual treatment plans.